Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret V Ragni

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Science (New York, N.Y.)|September 30, 2021
Hemophilia as a blueprint for gene therapyMargaret V Ragni
Current Opinion in Pulmonary Medicine|May 30, 2009
Pulmonary embolism and spiral computerized tomographic scansMargaret V Ragni
Hematology. American Society of Hematology. Education Program|December 10, 2013
The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disordersMargaret V Ragni
Blood|March 12, 2016
Platelet VIII pack evades immune detectionMargaret V Ragni
Hematology. American Society of Hematology. Education Program|December 10, 2017
Novel alternate hemostatic agents for patients with inhibitors: beyond bypass therapyMargaret V Ragni
Seminars in Thrombosis and Hemostasis|May 1, 2004
Hemophilia gene transfer: comparison with conventional protein replacement therapyMargaret V Ragni
Drugs|August 28, 2015
New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting ProteinsMargaret V Ragni
Hematology. American Society of Hematology. Education Program|December 7, 2019
Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's viewMargaret V Ragni
Blood Advances|January 4, 2018
Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand diseaseMargaret V Ragni
Expert Review of Hematology|September 24, 2011
Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis TrialMargaret V Ragni
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Science (New York, N.Y.)|September 30, 2021
Hemophilia as a blueprint for gene therapyMargaret V Ragni
Current Opinion in Pulmonary Medicine|May 30, 2009
Pulmonary embolism and spiral computerized tomographic scansMargaret V Ragni
Hematology. American Society of Hematology. Education Program|December 10, 2013
The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disordersMargaret V Ragni
Blood|March 12, 2016
Platelet VIII pack evades immune detectionMargaret V Ragni
Hematology. American Society of Hematology. Education Program|December 10, 2017
Novel alternate hemostatic agents for patients with inhibitors: beyond bypass therapyMargaret V Ragni
Seminars in Thrombosis and Hemostasis|May 1, 2004
Hemophilia gene transfer: comparison with conventional protein replacement therapyMargaret V Ragni
Drugs|August 28, 2015
New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting ProteinsMargaret V Ragni
Hematology. American Society of Hematology. Education Program|December 7, 2019
Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's viewMargaret V Ragni
Blood Advances|January 4, 2018
Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand diseaseMargaret V Ragni
Expert Review of Hematology|September 24, 2011
Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis TrialMargaret V Ragni
Pageof 12